1.
Efficacy, Safety and tolerability of the once-daily 10 cm² rivastigmine patch formulation in the patients with dementia (with probable Alzheimer’s disease). Bangla. J. Neuroscience [Internet]. 2013 Jan. 31 [cited 2026 Jul. 3];29(1):5-14. Available from: https://banglajol.info/index.php/BJN/article/view/56165